PFENEX INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2016-12: Study NCT03002428; Company role Lead sponsor; Phase Phase 3; Status Completed.
- 2015-12: Study NCT02656810; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2015-12: Study NCT02655549; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2015-03: Study NCT02474134; Company role Lead sponsor; Phase Phase 1; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2016-12 | NCT03002428 A Comparison of PF708 and Forteo in Osteoporosis Patients | Lead sponsor | Phase 3 | Completed | Osteoporosis | 181 | 2018-05 |
| 2015-12 | NCT02656810 A Comparison Study of PF708 and Forteo in Healthy Subjects | Lead sponsor | Phase 1 | Completed | Osteoporosis | 70 | 2016-07 |
| 2015-12 | NCT02655549 A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects | Lead sponsor | Phase 1 | Completed | Anthrax | 54 | 2017-06 |
| 2015-03 | NCT02474134 Comparison Study of PF530 and Betaferon in Healthy Subjects | Lead sponsor | Phase 1 | Completed | Multiple Sclerosis | 12 | 2015-10 |
| 2013-11 | NCT02121353 Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration | Lead sponsor | Phase 1, Phase 2 | Completed | Age Related Macular Degeneration (AMD) | 25 | 2016-01 |